Hexim1, a novel regulator of leptin function, modulates obesity and glucose disposal

Molecular Endocrinology

Volumn 30, Issue 3, 2016, Pages 314-324

  Dhar Mascareno, Manya ^a   Ramirez, Susan N ^a   Rozenberg, Inna ^b   Rouille, Yves ^c   Kral, John G ^b   Mascareno, Eduardo J ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c INSERM U1019   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER 4; HEXIM1 PROTEIN; JANUS KINASE 2; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REGULATOR PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; UNCLASSIFIED DRUG; HEXIM1 PROTEIN, MOUSE; JAK2 PROTEIN, MOUSE; PHOSPHOTYROSINE; SLC2A4 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ADAPTATION; ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENERGY BALANCE; HYPOTHALAMUS; MALE; METABOLIC STRESS; MOUSE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; 3T3 CELL LINE; ANIMAL; ARCUATE NUCLEUS; C57BL MOUSE; DRUG EFFECTS; HAPLOINSUFFICIENCY; HEK293 CELL LINE; HETEROZYGOTE; HUMAN; LIPID DIET; METABOLISM; WEIGHT GAIN;

3T3 CELLS; ADIPOGENESIS; ANIMALS; ARCUATE NUCLEUS OF HYPOTHALAMUS; DIET, HIGH-FAT; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HAPLOINSUFFICIENCY; HEK293 CELLS; HETEROZYGOTE; HUMANS; JANUS KINASE 2; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; OBESITY; PHOSPHOTYROSINE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; WEIGHT GAIN;

EID: 84959520701     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2015-1211     Document Type: Article

References (44)

1. Martí A, Berraondo B, Martínez JA. Leptin: physiological actions. J Physiol Biochem. 1999;55(1):43–49.
2. Villanueva EC, Myers MG Jr. Leptin receptor signaling and the regulation of mammalian physiology. Int J Obes. 2008;32(suppl 7):S8–S12.
3. Robertson SA, Leinninger GM, Myers MG Jr. Molecular and neural mediators of leptin action. Physiol Behav. 2008;94(5):637–642.
4. Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjørbaek C, Flier JS. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med. 2004;10(7): 734–738.
5. Yang Z, Hulver M, McMillan RP, et al. Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS One. 7(10):e47493.
6. Howard JK, Flier JS. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab. 2006;17(9):365–371.
7. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011;12(11):722–734.
8. Guo L, Li X, Tang QQ. Transcriptional regulation of adipocyte differentiation: a central role for CCAAT/enhancer-binding protein (C/EBP) β. J Biol Chem. 2015;290(2):755–761.
9. Zhou Q, Yik JH. The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Microbiol Mol Biol Rev. 2006;70(3):646–659.
10. Huang F, Wagner M, Siddiqui MA. Ablation of the CLP-1 gene leads to down-regulation of the HAND1 gene and abnormality of the left ventricle of the heart and fetal death. Mech Dev. 2004; 121(6):559–572.
11. Mascareno EJ, Belashov I, Siddiqui MA, Liu F, Dhar-Mascareno M. Hexim-1 modulates androgen receptor and the TGF-β signaling during the progression of prostate cancer. Prostate.72(9):1035–1044.
12. Mascareno E, Galatioto J, Rozenberg I, et al. Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β 1) signaling axis. J Biol Chem. 287(16):13084–13093.
13. Espinoza-Derout J, Wagner M, Salciccioli L, et al. Positive transcription elongation factor b activity in compensatory myocardial hypertrophy is regulated by cardiac lineage protein-1. Circ Res. 2009;104(12):1347–1354.
14. Kwak H, Lis JT. Control of transcriptional elongation. Annu Rev Genet. 2013;47:483–508.
15. Maures TJ, Kurzer JH, Carter-Su C. SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other. Trends Endocrinol Metab. 2007;18(1):38–45.
16. Galic S, Sachithanandan N, Kay TW, Steinberg GR. Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity. Biochem J. 2014; 461(2):177–188.
17. Rosen ED, Hsu CH, Wang X, et al. C/EBPα induces adipogenesis through PPARγ: a unified pathway. Genes Dev. 2002;16(1):22–26.
18. Iqbal J, Parks JS, Hussain MM. Lipid absorption defects in intestine-specific microsomal triglyceride transfer protein and ATPbinding cassette transporter A1-deficient mice. J Biol Chem. 2013; 288(42):30432–30444.
19. Belouzard S, Delcroix D, Rouillé Y. Low levels of expression of leptin receptor at the cell surface result from constitutive endocytosis and intracellular retention in the biosynthetic pathway. J Biol Chem. 2004;279(27):28499–28508.
20. Monni R, Santos SC, Mauchauffe M, et al. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells. Oncogene. 2001;20(7):849–858.
21. Sayyah J, Magis A, Ostrov DA, Allan RW, Braylan RC, Sayeski PP. Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth. Mol Cancer Ther. 2008;7(8):2308–2318.
22. Kallen CB, Lazar MA. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA. 1996;93(12):5793–5796.
23. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7(8):941–946.
24. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010;91(1):258S–261S.
25. Dey A, Chao SH, Lane DP. HEXIM1 and the control of transcription elongation: from cancer and inflammation to AIDS and cardiac hypertrophy. Cell Cycle. 2007;6(15):1856–1863.
26. Yarwood SJ, Borland G, Sands WA, Palmer TM. Identification of CCAAT/enhancer-binding proteins as exchange protein activated by cAMP-activated transcription factors that mediate the induction of the SOCS-3 gene. J Biol Chem. 2008;283(11):6843–6853.
27. Cui TX, Lin G, LaPensee CR, et al. C/EBPβ mediates growth hormone-regulated expression of multiple target genes. Mol Endocrinol. 25(4):681–693.
28. Liu Z, Gan L, Zhou Z, Jin W, Sun C. SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3 signaling pathway in 3T3-L1 adipocyte. Immunobiology. 2015;220(8):947–953.
29. Shen J, Tanida M, Niijima A, Nagai K. In vivo effects of leptin on autonomic nerve activity and lipolysis in rats. Neurosci Lett. 2007; 416(2):193–197.
30. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116(11):3015–3025.
31. Song XM, Ryder JW, Kawano Y, Chibalin AV, Krook A, Zierath JR. Muscle fiber type specificity in insulin signal transduction. Am J Physiol. 1999;277(6 pt 2):R1690–R1696.
32. Lillioja S, Young AA, Culter CL, et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest. 1987;80(2):415–424.
33. Gaster M, Staehr P, Beck-Nielsen H, Schrøder HD, Handberg A. GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes. 2001;50(6):1324–1329.
34. Armoni M, Harel C, Karnieli E. Transcriptional regulation of the GLUT4 gene: from PPAR-γ and FOXO1 to FFA and inflammation. Trends Endocrinol Metab. 2007;18(3):100–107.
35. Liu Y, Sweeney G. Adiponectin action in skeletal muscle. Best Pract Res Clin Endocrinol Metab. 2014;28(1):33–41.
36. Hevener AL, He W, Barak Y, et al. Muscle-specific Pparg deletion causes insulin resistance. Nat Med. 2003;9(12):1491–1497.
37. Wu Z, Xie Y, Morrison RF, Bucher NL, Farmer SR. PPARγ induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPβ during the conversion of 3T3 fibroblasts into adipocytes. J Clin Invest. 1998;101(1):22–32.
38. Wang L, Shao J, Muhlenkamp P, et al. Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancer-binding protein β. J Biol Chem. 2000; 275(19):14173–14181.
39. Rui L, Carter-Su C. Identification of SH2-bβ as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2. Proc Natl Acad Sci USA. 1999;96(13):7172–7177.
40. Song W, Ren D, Li W, et al. SH2B regulation of growth, metabolism, and longevity in both insects and mammals. Cell Metab. 2010; 11(5):427–437.
41. Valentino L, Pierre J. JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol. 2006;71(6):713–721.
42. Zouein FA, Duhe RJ, Booz GW. JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth. Growth Factors. 29(6):245–252.
43. Ouchida R, Kusuhara M, Shimizu N, et al. Suppression of NF-κBdependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells. Genes Cells. 2003;8(2):95–107.
44. Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res. 2005;96(10): 1042–1052.